Zobrazeno 1 - 10
of 37
pro vyhledávání: '"E. N. Atkinson"'
Publikováno v:
Cancer Chemotherapy and Pharmacology. 29:485-489
PANC02 is a ductal adenocarcinoma of the pancreas that is resistant to every known class of clinically active antitumor agent. To study the mechanism(s) underlying the intrinsic drug resistance of this tumor, a mammary adenocarcinoma (CA-755) that al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e68f82fa7ec9fd71e6decb55c5d9221
https://doi.org/10.1007/bf00684853
https://doi.org/10.1007/bf00684853
Publikováno v:
Archives of Gynecology and Obstetrics. 254:940-942
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1edc169a00fae071523d353831124fe
https://doi.org/10.1007/bf02266245
https://doi.org/10.1007/bf02266245
Autor:
M, Follen, E N, Atkinson, D, Schottenfeld, A, Malpica, L, West, S, Lippman, C, Zou, W N, Hittelman, R, Lotan, W K, Hong
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(11)
Previous trials of topical trans-retinoic acid treatment of cervical intraepithelial neoplasia (CIN) grades 2 and 3 led to a statistically significant regression of CIN 2, but not CIN 3. We tested N-(4-hydroxyphenyl)retinamide (4-HPR), a promising or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20cd399e59935166c7f7a4d90c012f87
https://pubmed.ncbi.nlm.nih.gov/11705848
https://pubmed.ncbi.nlm.nih.gov/11705848
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(9)
Chemotherapy given sequentially or concurrently with external beam radiation therapy has emerged as a standard for the treatment of locally advanced lung cancer. Gene therapy by adenovirus-mediated wild-type p53 gene transfer has been shown to inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be39480eaab7d0850ed724154887ad88
https://pubmed.ncbi.nlm.nih.gov/11555607
https://pubmed.ncbi.nlm.nih.gov/11555607
Autor:
A, Hoque, S M, Lippman, I V, Boiko, E N, Atkinson, N, Sneige, A, Sahin, D M, Weber, S, Risin, M D, Lagios, R, Schwarting, W J, Colburn, K, Dhingra, M, Follen, G J, Kelloff, C W, Boone, W N, Hittelman
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(3)
Clinical management of ductal carcinoma in situ (DCIS) remains a challenge because significant proportions of patients experience recurrence after conservative surgical treatment. Unfortunately, it is difficult to prospectively identify, using object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27d378aad52439e86e4537e5bc23b7ce
https://pubmed.ncbi.nlm.nih.gov/11303595
https://pubmed.ncbi.nlm.nih.gov/11303595
Autor:
R S, Freedman, A P, Kudelka, J J, Kavanagh, C, Verschraegen, C L, Edwards, M, Nash, L, Levy, E N, Atkinson, H Z, Zhang, B, Melichar, R, Patenia, S, Templin, W, Scott, C D, Platsoucas
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(6)
To identify strategies that enhance tumor-specific immunity in patients with ovarian carcinoma, 22 patients received four to six doses of i.p. recombinant IFN-gamma (rIFN-gamma), 200 microg/m2 on days 1, 3, 5, 8, 10, and 12, and i.p. recombinant inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49660ed7100e0cc23d822b750f7d2be1
https://pubmed.ncbi.nlm.nih.gov/10873077
https://pubmed.ncbi.nlm.nih.gov/10873077
Autor:
D M, Gershenson, M, Morris, T W, Burke, C, Levenback, J, Wolf, J J, Lee, P F, Thall, E N, Atkinson, E G, Silva, J T, Wharton
Publikováno v:
Cancer. 86(11)
The primary purpose of this study was to establish the maximum tolerated dose (MTD) of intravenous melphalan in combination with paclitaxel and cisplatin plus granulocyte-colony stimulating factor (G-CSF) in patients with suboptimal advanced epitheli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad672d2ccebd1bdafca1d14282f24a1e
https://pubmed.ncbi.nlm.nih.gov/10590370
https://pubmed.ncbi.nlm.nih.gov/10590370
Autor:
M E, Gordinier, H Z, Zhang, R, Patenia, L B, Levy, E N, Atkinson, M A, Nash, R L, Katz, C D, Platsoucas, R S, Freedman
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(9)
Transforming growth factor beta (TGF-beta) is an important family of cytokines that may promote tumor growth in vivo through several mechanisms including interference with antitumor T-cell immune responses, alteration of factors in the stroma and mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b65320aaf471967ad3d02241b02f782d
https://pubmed.ncbi.nlm.nih.gov/10499625
https://pubmed.ncbi.nlm.nih.gov/10499625
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(9)
The purpose of this study was to correlate physical examination and sonographic and mammographic measurements of breast tumors and regional lymph nodes with pathological findings and to evaluate the effect of neoadjuvant chemotherapy on clinical Tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93474c23f7ff79d1a4bf0ce96350cbc1
https://pubmed.ncbi.nlm.nih.gov/9815844
https://pubmed.ncbi.nlm.nih.gov/9815844
Publikováno v:
Cancer research. 58(21)
Low levels of gene expression following systemic delivery have impaired the effectiveness of tumor suppressor gene replacement in treating metastases. We asked whether combined treatment with 2-methoxyestradiol (2-Me), which increases levels of wild-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d2815b0542025989281b684c1a6870e8
https://pubmed.ncbi.nlm.nih.gov/9809972
https://pubmed.ncbi.nlm.nih.gov/9809972